Credit Suisse’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Credit Suisse’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-111,124	Closed	-$3.76M	–	4682
2021 Q2	$3.76M	Buy	111,124 +87,042	+361%	+$2.22M	﹤0.01%	2327
2021 Q1	$563K	Sell	24,082 -30,782	-56%	-$932K	﹤0.01%	3695
2020 Q4	$1.58M	Sell	54,864 -29,025	-35%	-$731K	﹤0.01%	3007
2020 Q3	$1.7M	Buy	83,889 +26,229	+45%	+$640K	﹤0.01%	2540
2020 Q2	$1.73M	Buy	+57,660	New	+$2.08M	﹤0.01%	2501
2020 Q1	–	Sell	-14,194	Closed	-$669K	–	4345
2019 Q4	$669K	Buy	+14,194	New	+$410K	﹤0.01%	3397

Credit Suisse's CNST Position: Q3 2021 in Review

Credit Suisse sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 111,124 shares — an estimated $3.76M sold.

Credit Suisse first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $3.76M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Credit Suisse reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Credit Suisse sold 111,124 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3.76M.
Credit Suisse first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
Credit Suisse's Constellation Pharmaceuticals, Inc. position peaked at $3.76M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.